Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novan, Inc.
A randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.
Age
12–40
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Moderate to severe acne
25-70 non-inflammatory lesions at Baseline
20-40 inflammatory lesions at Baseline
You may not be if
Subjects with known allergy to any component of the test material or vehicle
